214 related articles for article (PubMed ID: 22151972)
21. [Granulocyte colony-stimulating factor in the treatment of febrile neutropenia].
López-Hernández MA; Jiménez-Alvarado R; Borbolla-Escoboza R; de Diego Flores-Chapa J; Alvarado-Ibarra M; González-Avante M; Trueba-Chrysti ME; Anaya-Cuéllar I
Gac Med Mex; 2000; 136(2):99-105. PubMed ID: 10815320
[TBL] [Abstract][Full Text] [Related]
22. Granulocyte-macrophage colony stimulating factor treatment of febrile neutropenia following remission induction chemotherapy for acute leukemia.
Cucuianu A; Petrov L; Ghiurt A; Vasilache A
Rom J Intern Med; 1996; 34(1-2):97-103. PubMed ID: 8908636
[TBL] [Abstract][Full Text] [Related]
23. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
[TBL] [Abstract][Full Text] [Related]
24. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
[TBL] [Abstract][Full Text] [Related]
25. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
[TBL] [Abstract][Full Text] [Related]
26. Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
Malagola M; Peli A; Damiani D; Candoni A; Tiribelli M; Martinelli G; Piccaluga PP; Paolini S; De Rosa F; Lauria F; Bocchia M; Gobbi M; Pierri I; Zaccaria A; Zuffa E; Mazza P; Priccolo G; Gugliotta L; Bonini A; Visani G; Skert C; Bergonzi C; Roccaro AM; Filì C; Fanin R; Baccarani M; Russo D
Eur J Haematol; 2008 Nov; 81(5):354-63. PubMed ID: 18637030
[TBL] [Abstract][Full Text] [Related]
27. Successful management of invasive aspergillosis with voriconazole and amphoteracin B therapy in a patient with acute mycloid leukemia (AML-M2).
Manzoor NF; Azim S; Fadoo Z
J Pak Med Assoc; 2010 Nov; 60(11):977-9. PubMed ID: 21375212
[TBL] [Abstract][Full Text] [Related]
28. Assessment of febrile neutropenia episodes in children with acute leukemia treated with BFM protocols.
Yilmaz S; Oren H; Demircioğlu F; Irken G
Pediatr Hematol Oncol; 2008; 25(3):195-204. PubMed ID: 18432502
[TBL] [Abstract][Full Text] [Related]
29. Empirical antifungal therapy in selected patients with persistent febrile neutropenia.
Aguilar-Guisado M; Espigado I; Cordero E; Noguer M; Parody R; Pachón J; Cisneros JM
Bone Marrow Transplant; 2010 Jan; 45(1):159-64. PubMed ID: 19525983
[TBL] [Abstract][Full Text] [Related]
30. Hepatosplenic fungal infection in adult patients with acute leukemia.
Ma MC; Wang MC; Pei SN; Kuo CY
Chang Gung Med J; 2008; 31(1):74-80. PubMed ID: 18419056
[TBL] [Abstract][Full Text] [Related]
31. Randomized comparison of antibiotics with and without granulocyte colony-stimulating factor in children with chemotherapy-induced febrile neutropenia: a report from the Children's Oncology Group.
Ozkaynak MF; Krailo M; Chen Z; Feusner J
Pediatr Blood Cancer; 2005 Sep; 45(3):274-80. PubMed ID: 15806544
[TBL] [Abstract][Full Text] [Related]
32. Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy.
Mattiuzzi GN; Kantarjian H; Faderl S; Lim J; Kontoyiannis D; Thomas D; Wierda W; Raad I; Garcia-Manero G; Zhou X; Ferrajoli A; Bekele N; Estey E
Cancer; 2004 Feb; 100(3):581-9. PubMed ID: 14745876
[TBL] [Abstract][Full Text] [Related]
33. Febrile neutropenia in haematological malignancies.
Sharma A; Lokeshwar N
J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
[TBL] [Abstract][Full Text] [Related]
34. Risks and outcome of fungal infection in neutropenic children with hematologic diseases.
Aytaç S; Yildirim I; Ceyhan M; Cetin M; Tuncer M; Kara A; Cengiz AB; Seçmeer G; Yetgin S
Turk J Pediatr; 2010; 52(2):121-5. PubMed ID: 20560245
[TBL] [Abstract][Full Text] [Related]
35. [Empirical antibiotic treatment of patients with acute myelogenous leukemia].
Tangen JM; Berentsen S; Dahl IM; Ly B; Myrvang B
Tidsskr Nor Laegeforen; 1999 Jan; 119(1):35-8. PubMed ID: 10025202
[TBL] [Abstract][Full Text] [Related]
36. Invasive fungal infections in pediatric patients with hematologic malignancies receiving oral amphotericin B solution and early intravenous administration of fluconazole.
Watanabe N; Matsumoto K; Kojima S; Kato K
J Pediatr Hematol Oncol; 2011 May; 33(4):270-5. PubMed ID: 21464763
[TBL] [Abstract][Full Text] [Related]
37. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
[TBL] [Abstract][Full Text] [Related]
38. [Criteria of low risk of mortality in children with neutropenia and fever during cancer chemotherapy].
Paganini HR; Rodríguez Brieshcke T; Zubizarreta P; Latella A; Firpo V; Fernandez C; Armada A; Casimir L; Debbag R
Medicina (B Aires); 2001; 61(1):63-6. PubMed ID: 11265626
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of acute leukemia complicated by invasive aspergillosis in children].
Liu Y; Tang SQ; Wang JW; Long H; Feng C; Zhang H
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov; 11(11):901-4. PubMed ID: 20113657
[TBL] [Abstract][Full Text] [Related]
40. Compliance with a critical pathway for the management of febrile neutropenia and impact on clinical outcomes.
Zuckermann J; Moreira LB; Stoll P; Moreira LM; Kuchenbecker RS; Polanczyk CA
Ann Hematol; 2008 Feb; 87(2):139-45. PubMed ID: 17938926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
